FY24 Cash Generation Target
Management expects to generate INR 400+ crore cash in FY24, building on Q1's INR 18 crore positive cash generation.
POLICYBZR / guidance tracker
Keep management guidance in view.
PB Fintech · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
growth
FY26-27 PAT Guidance Maintained
INR 1,000 crore PAT guidance for FY26-27 remains unchanged; management expressed higher confidence for FY24 delivery within this trajectory.
New Initiatives Investment Range
Annual investment in new initiatives (POSP, PB Partners, UAE) capped at INR 150-250 crore, down from ~INR 146 crore in Q1 FY23 to INR 34 crore in Q1 FY24.
Paisabazaar EBITDA Margin Trajectory
Targeting ~20% EBITDA-to-revenue ratio in a reasonable timeframe, currently at 6-7%, as renewal revenue (14% of credit revenue) and operating leverage improve margins.
Full-year renewal premium growth targeted at 45-46%
Management explicitly guided that despite Q1 renewal ARR being lower at 34% due to slower new business growth 12 months ago, full-year renewal premium will reach 45-46%, with Q2 at 40+%, improving through the year.
Credit business recovery expected in H2 FY25
Paisabazaar CEO Naveen Kukreja guided that industry unsecured credit recovery will resume in H2 FY25, with secured business expected to grow faster and eventually reach 50% of total disbursements (currently 15%).
Paisabazaar strategic clarity in 1-2 quarters
Chairman Yashish Dahiya indicated the board is rethinking Paisabazaar's direction—potentially pivoting toward secured lending (similar to European fintech remortgage markets)—with clarity expected in 1-2 quarters.
PB Money pilot launch in Q2, PB Rewards in Q3-Q4
Naveen Kukreja guided that personal finance management products leveraging the Account Aggregator framework will pilot in Q2, with loyalty/rewards pilots following in Q3-Q4, with no significant cost impact expected.
2030 Premium Target: INR 1 Lakh Crore
Management reiterated its long-term goal of reaching INR 1 lakh crore of insurance premium by 2030, viewing this as the "North Pole" goal over near-term profitability.
Insurance Revenue Growth: ~45% for Foreseeable Future
Current insurance revenue growth of 47% is expected to moderate to approximately 45% range, sustaining double-digit expansion over the medium term.
New Initiatives to Near-Breakeven by FY27
Directionally, new initiatives (POSP, UAE, Corporate) should be "very close to zero" from EBITDA perspective by next year, with long-term sustainable margin around 5%.
Credit Business Recovery in Q3 FY26
Paisabazaar expects credit disbursals and quality to inflect positively from Q3, after using Q1-Q2 to build backend operations and digital integrations.
Tax Rate: 8-10% for Next 18 Months
Effective tax rate expected to remain around 8-10% due to accumulated carry-forward losses benefit, consistent with long-term profitability guidance framework.
First full-year PAT positive in FY24
Management expressed high confidence that Q2 FY24 will be the last loss-making quarter, with Q3 and Q4 historically stronger and on track for full-year profitability.
Health + Term growth guided at 30-35%
The 53% growth in Q2 was described as overperformance; management continues to guide sustainable growth of 30-35% for the protection business going forward.
Renewal Trail ARR at ₹436 crore with 85% margin
Renewal trail provides predictable, high-margin revenue growing from ₹294 crore last year. Management sees this as significant source of profit growth.
EBITDA delta of ₹225 crore over six quarters
Core business adjusted EBITDA improved by ₹225 crore year-over-year over the past six quarters, exceeding the initial guidance of ₹150-200 crore.
Medium-term revenue growth target of ~30%
Despite current 60-70% growth rates, management maintains 30% as the steady-state medium-term target for core insurance fresh business growth, consistent with long-term guidance provided since IPO.
FY25 free cash flow of ~$60 million
Management expects FY25 free cash flow of approximately $60 million, with FY26 projected to exceed $100 million as profitability continues to improve.
PB Health investment limit of $0-$100 million
Policybazaar board may consider a one-time investment of up to $100 million in the PB Health initiative post-approval, positioned as strategic enablement rather than financial investment.
ESOP charges to flatten or reduce
ESOP amortization expenses are expected to stabilize and potentially decrease going forward from current levels.
INR 1 Trillion Premium Target by ~2030
Management reaffirmed its aspiration for INR 1 lakh crore (INR 1 trillion) of insurance premium, potentially delayed by 1-2 quarters due to GST changes. GST exemption removes ~6% from the cumulative book.
3% PAT/ Premium by FY30
Long-term profit target of approximately 3% of premium (vs current 1.77%) as the business scales to INR 1 trillion premium. Management calls this a 'robust' number not easily changed.
New Initiatives Adjusted EBITDA Near-Zero by FY27
Combined POSP, corporate, and UAE contribution margins at 5.5% currently. Management expects new initiatives to be 'very close to zero' adjusted EBITDA loss next fiscal year, with UAE already profitable and POSP losses reducing significantly.
30%+ Growth Excluding Savings
Excluding the stressed savings category, the company has grown between 35-45% YoY for the last 10 consecutive quarters and anticipates maintaining this trajectory as Q3/Q4 last year had lower savings bases.
FY27 PAT Target: INR 1,000 crore
Management reaffirmed commitment to INR 1,000 crore PAT by FY2027, building on FY24 PAT positive achievement ahead of schedule.
Credit Business: 30% growth next quarter, recovery to 40% thereafter
Paisabazaar expects 10% growth delta reduction (from 40% to ~30%) for next quarter due to unsecured credit partner recalibration, normalizing afterward.
Long-term ESOP charge: ~INR 100 crore annually
ESOP charges to decline from INR 330-350 crore to ~INR 100 crore as IPO-related grants vest. This represents normalized future compensation cost.
Adjusted EBITDA improving INR 200+ crore annually
Company has grown adjusted EBITDA by more than INR 50 crore per quarter for 6-7 quarters, on track for INR 200 crore+ annual improvement through revenue growth and operating leverage.
FY27 Net Income Target: INR 1,000+ Crore
Management reiterated the November 2021 guidance based on renewals doubling every two years, stating current trajectory supports easy achievement.
Healthcare Business Investor Announcement in ~30 Days
Board authorized negotiations 45 days ago; deep negotiations ongoing with identified investors for potential strategic partnership.
Cost Optimization from April Onward
1,500-2,000 vacant office seats being vacated; notices given with depreciation and financing cost savings expected from Q4 FY25.
No Short-Term Profitability Guidance
Management explicitly declined to provide quarterly profit guidance, prioritizing growth over near-term profitability given 40%+ revenue growth rates.
New Initiatives Break-even Target
Management expects new initiatives (beyond core Policybazaar and Paisabazaar) to be at break-even or profitable going forward, as contribution margin has improved from -7% to -3% and the business scales.
QIP for International Expansion
Board meeting scheduled to seek approval for QIP to fund international expansion. Markets being considered include Southeast Asia and Europe; criteria include large market size, strategic fit, and familiarity with regulatory dynamics.
Health Insurance Growth Normalization
Management acknowledged the 79% health growth includes a 20-30 percentage point benefit from GST-related demand surge and expects growth to normalize toward a long-term sustainable level of around 30% going forward.
PB Health Hospital Launches
Gurgaon hospital expected to go live in approximately three months; network development ongoing with four properties at various stages of development. Focus remains on secondary/tertiary care routing and preventive health services.
Paisabazaar Growth Moderation
Management expects Paisabazaar growth to be 0-10% for at least one more quarter due to process-based (not quality-based) tightening that is expected to ease shortly.
Growth Priority Over Margins
Yashish explicitly stated 'growth is a priority, massive priority' while profit is 'like counting the bogies going through of the train' as renewals drive profitability.
Brand Spend Below Revenue Growth
Sarbvir indicated brand costs increase roughly at half the rate of premium growth, and the company will continue to grow brand spending in FY25 as ROI remains positive.
New Initiatives Breakeven Achieved
New initiatives (including PB Partners) broke even at a contribution level, with PB Partner growing 50% QoQ and expanding to 18,000 PIN codes covering 93% of India.
30% CAGR Revenue Growth Target
Management maintains 30% as the right long-term CAGR for planning purposes, though 5-year actual CAGR of 43% has surprised to upside. Health segment has potential to double from current levels based on competitive positioning.
Savings Business Pressure Through H1 FY26
Savings segment expected to remain challenged for first two quarters of new financial year. Team focused on building new segments like pension and reintroducing products like Capital Guarantee Solution.
New Initiatives Break-Even Timeline
Corporate and POSP businesses expected to reach break-even in approximately two years. UAE already profitable but not yet material to overall profitability (contributing ~10-20% to loss reduction).
Credit Business Secured Expansion
Paisabazaar will expand into home loans, loan against property, and loan against car in FY26. Collections capability development to support unsecured lending scale-up.
FY27 new insurance premium growth target
Management expects to grow ~30% (their stated steady-state guidance) but confidence that they will beat this significantly. Stated: 'We will beat last year' and 'What we will do is in one year, we will give the growth of what we promised in two years.'
POSP expansion aggression
Management signaled very aggressive expansion plans for POSP business in FY27, citing improved model for smaller cities, competitive landscape consolidation, and opportunity to deepen penetration while quality metrics are at all-time highs.
Paisabazaar profitability trajectory
Expects to be 'significantly positive' on EBITDA next year with operating leverage as fixed costs stabilize and revenue scales. CSAT improved from 72% to 90%, conversion rates rising with supply partnerships strengthening.